tak-875
Showing 1 - 12 of 12
Diabetes, Type 2 Trial in Worldwide (TAK-875, TAK-875 Placebo, Glimepiride)
Terminated
- Diabetes Mellitus, Type 2
- TAK-875
- +2 more
-
Muscle Shoals, Alabama
- +68 more
Apr 24, 2016
Diabetes, Type 2 Trial in Guatemala, Mexico, United States (TAK-875, Glimepiride, Placebo)
Completed
- Diabetes Mellitus, Type 2
- TAK-875
- +2 more
-
Birmingham, Alabama
- +70 more
Mar 13, 2016
Diabetes, Type 2 Trial in United States (Placebo, TAK-875, Sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- Placebo
- +3 more
-
Birmingham, Alabama
- +79 more
Mar 4, 2016
Diabetes, Type 2 Trial in Worldwide (TAK-875, Glimepiride)
Type 2 Diabetes Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes Mellitus
- TAK-875
- TAK-875 Placebo
-
Brookvale, New South Wales, Australia
- +52 more
Oct 15, 2015
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes
- Cardiovascular Disease
- TAK-875
- TAK-875 Placebo
-
Birmingham, Alabama
- +587 more
Oct 15, 2015
Diabetes Trial in Japan (TAK-875)
Completed
- Diabetes Mellitus
- TAK-875
-
Nagoya-shi, Aichi, Japan
- +70 more
Jan 24, 2014
Diabetic Patients Trial in Fukuoka-shi, Sumida-ku (TAK-875, Glimepiride, Placebo)
Completed
- Diabetic Patients
- TAK-875
- +2 more
-
Fukuoka-shi, Fukuoka, Japan
- +1 more
Apr 15, 2013
Diabetes Trial in Japan (TAK-875)
Completed
- Diabetes Mellitus
- TAK-875
-
Katori-shi, Chiba, Japan
- +30 more
Mar 21, 2013
Diabetes Trial in Japan (TAK-875, Placebo)
Completed
- Diabetes Mellitus
- TAK-875
- Placebo
-
Kisarazu-shi, Chiba, Japan
- +18 more
Nov 7, 2012
Diabetes, Type 2 Trial (TAK-875)
Completed
- Diabetes Mellitus, Type 2
- TAK-875
- (no location specified)
Jun 9, 2010